The Center of Excellence in Neurodevelopmental Disorders
The Friedman Brain Institute’s Center of Excellence in Neurodevelopmental Disorders in New York City is committed to the prevention and cure of neurodevelopmental disorders, which include:
- Anxiety disorders
- Autism and related disorders
- Attention-deficit/hyperactivity disorder
- Bipolar disorder
- Brain malformations
- Cerebral palsy
- Developmental delay
- Intellectual disability
- Learning disabilitiy
- Mood disorders
- Obsessive-compulsive disorder
- Speech and language problems
- Tic disorders
Research and treatment in these domains is available at Icahn School of Medicine, its Friedman Brain Institute, and Mount Sinai's Children's Health and Development Institute.
The Center of Excellence in Neurodevelopmental Disorders has a particular focus in the areas of autism and related conditions, attention-deficit/hyperactivity disorder, intellectual disabilities and developmental delays, anxiety and mood disorders, and schizophrenia. Our mission, which is realized through collaborative efforts with expert researchers and clinicians, is to discover the causes of these disorders and use that information to guide us on the path to innovative clinical therapies.
Joseph Buxbaum, MSc, PhD is the Chief for the Center of Excellence on Neurodevelopment Disorders, Director of the Seaver Autism Center, Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences.
Joseph D. Buxbaum, MSc, PhD